XML 22 R7.htm IDEA: XBRL DOCUMENT v3.25.4
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Cash flows from operating activities:      
Net loss $ (18,674) $ (68,542) $ (27,022)
Adjustments to reconcile net loss to net cash used in operations      
Depreciation and intangibles amortization 4,403 3,798 3,307
Amortization of issuance costs 2,059 925
Change in fair value of derivative liability (11,750) 40,532 (528)
Change in value of derivative (666)
Provision for credit losses 279 279
Amortization of operating lease right-of-use assets 540 294 222
Stock-based compensation expense 8,659 5,782 4,271
Stock-based compensation expense for services 18 23 284
Change in operating assets and liabilities      
Accounts receivable (492) 38 (52)
Inventory (334) 55 (70)
Accrued interest receivable (8,185)
Prepaid expenses and other current assets (11,753) 16 (110)
Other non-current assets (2) (69)
Accounts payable (594) (90) 596
Deferred revenue 316 79
Accrued expenses and other current liabilities 7,966 362 (112)
Operating lease liabilities (412) (236) (241)
Net cash used in operating activities (30,294) (16,213) (18,315)
Cash flows from investing activities:      
Purchase of property and equipment (6,690) (6,036) (2,112)
Issuance of loan receivable (500)
Purchases of available-for-sale debt securities (1,197,865)
Proceeds from sales of available-for-sale debt securities 376,331
Proceeds from maturities of available-for-sale debt securities 39,904
Other recognized losses (gains) (7)
Net cash used in investing activities (788,327) (6,036) (2,612)
Cash flows from financing activities:      
Proceeds raised from financial liabilities, net of issuance costs 6,995
Payments of financial liabilities, net of interest (10,313) (6,187)
Series A Preferred stock dividend payments (215) (865)
Repurchase of Series A preferred stock (4,098)
Proceeds from stock issuance related to ATM facility
Net proceeds from exercise of warrants 2,412
Net proceeds from issuance of common stock 1,475,144 106,766 24,730
Net cash provided by financing activities 1,477,556 99,135 17,678
Net increase (decrease) in cash 658,935 76,886 (3,249)
Cash and cash equivalents, beginning of period 78,945 2,059 5,308
Cash and cash equivalents, end of period 737,880 78,945 2,059
Supplemental disclosures of cash flow information:      
Cash paid for interest 268 813
Non-cash investing and financing activities:      
Fair value of derivative liability reclassed to additional paid-in capital due to exercise of warrants 21,009
Issuance of stock expensed from 2024, awarded in 2025 1,507
Leased assets obtained in exchange for new operating lease liabilities 1,371 765
Reclassification of Series A preferred stock to mezzanine equity 8,195
Valuation of derivative associated with convertible financial liability 666
Conversion of Series A preferred to common stock $ 4,097